Anagnostouli MC, Velonakis G, Dalakas MC (2021) Aggressive herpes zoster in young patients with multiple sclerosis under Dimethyl Fumarate: significance of CD8+ and natural killer cells. Neurol Neuroimmunol Neuroinflamm 8(4):e1017 Published 2021 May 28. https://doi.org/10.1212/NXI.0000000000001017

Article  PubMed  PubMed Central  Google Scholar 

Anderson TC, Masters NB, Guo A et al (2022) Use of recombinant zoster vaccine in immunocompromised adults aged ⩾19 years: recommendations of the Advisory Committee on Immunization practices—United States, 2022. MMWR Morb Mortal Wkly Rep 71:80–84

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arvin AM, Wolinsky JS, Kappos L et al (2015) Varicella-Zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol 72(1):31–39. https://doi.org/10.1001/jamaneurol.2014.3065

Article  PubMed  PubMed Central  Google Scholar 

Balshi A, Saart E, Pandeya S, Dempsey J, Baber U, Sloane JA (2023) High CD4+:CD8 + ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate. Mult Scler 29(11–12):1465–1470. https://doi.org/10.1177/13524585231189641

Article  CAS  PubMed  Google Scholar 

Balshi A, Manning N, Dempsey J, Kumbar S, Baber U, Sloane JA (2024) Altered lymphocyte profiles and herpes zoster infections in patients with multiple sclerosis on natalizumab. Mult Scler. Published Online June 16. https://doi.org/10.1177/13524585241260537

Gold R, Arnold DL, Bar-Or A et al (2022) Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: final ENDORSE study results. Mult Scler 28(5):801–816. https://doi.org/10.1177/13524585211037909

Article  CAS  PubMed  Google Scholar 

Ma BB, Ostrow LW, Newsome SD (2016) Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm 3(2):e203 Published 2016 Mar 9. https://doi.org/10.1212/NXI.0000000000000203

Article  PubMed  PubMed Central  Google Scholar 

Spencer CM, Crabtree-Hartman EC, Lehmann-Horn K, Cree BA, Zamvil SS (2015) Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm 2(3):e76 Published 2015 Feb 12. https://doi.org/10.1212/NXI.0000000000000076

Article  PubMed  PubMed Central  Google Scholar 

Weinberg A, Levin MJ (2010) VZV T cell-mediated immunity. Curr Top Microbiol Immunol 342:341–357. https://doi.org/10.1007/82_2010_31

Article  CAS  PubMed  Google Scholar